☆ 4.1 Meeting Abstract

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)

Journal

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Volume 52, Issue 1, Pages 76-77

Publisher

DUSTRI-VERLAG DR KARL FEISTLE

DOI: 10.5414/CPXCES13EA02

Keywords

glioblastoma; DC-CIT; dendritic cells; AV0113

Categories

Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.